You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Selinexor

Showing 101 - 125 of 137
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapse/Refractory Multiple Myeloma Trial in China (ATG-010)

Completed
  • Relapse/Refractory Multiple Myeloma
  • Beijing, Beijing, China
  • +16 more
Jul 27, 2022

Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma Trial in United States (Selinexor, Ixazomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Relapsed and/or Refractory Multiple Myeloma
  • Selinexor
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Nov 23, 2020

Maximum Tolerated Dose, GIST, Metastatic Adult Soft Tissue Sarcoma Trial in Spain (Selinexor, Imatinib)

Recruiting
  • Maximum Tolerated Dose
  • +4 more
  • Sevilla, Andalucia, Spain
  • +5 more
Oct 21, 2020

Peripheral T-cell Lymphoma (PTCL), Cutaneous T-cell Lymphoma (CTCL) Trial in Australia, Singapore (Selinexor)

Terminated
Has Results
  • Peripheral T-cell Lymphoma (PTCL)
  • Cutaneous T-cell Lymphoma (CTCL)
  • Selinexor
  • Concord, New South Wales, Australia
  • +4 more
Sep 8, 2020

Solid Tumors Trial in Singapore (KPT-330)

Completed
  • Solid Tumors
  • Singapore, Singapore
    National University Hospital
Sep 8, 2020

Squamous Cell Carcinoma Trial in Canada, United States (Selinexor (KPT-330))

Terminated
Has Results
  • Squamous Cell Carcinoma
  • Selinexor (KPT-330)
  • Aurora, Colorado
  • +17 more
Nov 6, 2020

Acute Myeloid Leukemia Trial in Spain (Selinexor, fludarabine, idarubicin)

Completed
  • Acute Myeloid Leukemia
  • Selinexor
  • +4 more
  • Badalona, Spain
  • +3 more
May 19, 2020

Richter's Transformation Trial in Worldwide (selinexor)

Terminated
Has Results
  • Richter's Transformation
  • selinexor
  • Tucson, Arizona
  • +16 more
Sep 8, 2020

Acute Myeloid Leukemia Trial in Chicago (Cytarabine, Mitoxantrone Hydrochloride, Selinexor)

Completed
  • Acute Myeloid Leukemia
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Apr 6, 2020

Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,

Recruiting
  • Relapsed Refractory Multiple Myeloma
  • Abemaciclib, dexamethasone, ixazomib, pomalidomide
  • +7 more
  • Phoenix, Arizona
  • +16 more
Sep 9, 2021

Leukemia, Acute Myeloid Leukemia Trial in Houston (Selinexor, Sorafenib)

Completed
Has Results
  • Leukemia
  • Acute Myeloid Leukemia
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Mar 18, 2020

Acute Myeloid Leukemia Trial in Saint Louis (Selinexor, Cladribine, G-CSF)

Completed
Has Results
  • Acute Myeloid Leukemia
  • Selinexor
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 6, 2020

Acute Myeloid Leukemia (AML) Trial in United States (Selinexor, Fludarabine, Cytarabine)

Terminated
Has Results
  • Acute Myeloid Leukemia (AML)
  • Selinexor
  • +3 more
  • Phoenix, Arizona
  • +6 more
May 20, 2020

Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Myelodysplastic Syndrome (MDS) Trial in United States

Completed
  • Acute Myeloid Leukemia (AML)
  • +3 more
  • Selinexor
  • +3 more
  • Phoenix, Arizona
  • +5 more
Mar 25, 2020

Relapsed/Refractory DLBCL (DLBCL) Trial in China (ATG-010 60 mg, orally, twice weekly, each 4 week (28-day) a cycle)

Recruiting
  • Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
  • ATG-010 60 mg, orally, twice weekly, each 4 week (28-day) a cycle
  • Beijing, Beijing, China
  • +14 more
Jul 19, 2021

Relapsed or Refractory Multiple Myeloma Trial in China (SVd (Selinexor+Bortezomib+dexamethasone), Vd (Bortezomib+dexamethasone))

Recruiting
  • Relapsed or Refractory Multiple Myeloma
  • SVd (Selinexor+Bortezomib+dexamethasone)
  • Vd (Bortezomib+dexamethasone)
  • Hefei, Anhui, China
  • +33 more
Aug 14, 2022

Hematological Malignancies Trial in Canada, Denmark, United States (KPT-330)

Completed
Has Results
  • Hematological Malignancies
  • Tampa, Florida
  • +11 more
Mar 5, 2021

Multiple Myeloma Trial in Worldwide (Selinexor, Bortezomib, Dexamethasone)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Selinexor
  • +2 more
  • Plantation, Florida
  • +156 more
Nov 23, 2021

Carcinoma, Neuroendocrine Trial in Canton (Selinexor)

Completed
  • Carcinoma, Neuroendocrine
  • Selinexor
  • Canton, Ohio
    Gabrail Cancer Center Research
Sep 13, 2019

Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo (behavioral, drug, other)

Recruiting
  • Plasma Cell Myeloma
  • +3 more
  • Behavioral Intervention
  • +6 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 5, 2022

Multiple Myeloma Trial (Selinexor)

No longer available
  • Multiple Myeloma
  • Selinexor
  • (no location specified)
Feb 20, 2019

CAEBV Trial in Beijing (Selinexol and Dexamethasone)

Not yet recruiting
  • CAEBV
  • Selinexol and Dexamethasone
  • Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Apr 21, 2022

Relapsed and Refractory Multiple Myeloma Trial in Pittsburgh (Mezigdomide, Ixazomib, Dexamethasone)

Not yet recruiting
  • Relapsed and Refractory Multiple Myeloma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 15, 2023

Solid Tumors Trial in United States (SL-801)

Terminated
  • Solid Tumors
  • New Haven, Connecticut
  • +5 more
Jan 27, 2022

Castration Levels of Testosterone, Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma in the Soft Tissue Trial in

Terminated
Has Results
  • Castration Levels of Testosterone
  • +5 more
  • Selinexor
  • San Francisco, California
    University of California, San Francisco
May 29, 2018